{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:58:28Z","timestamp":1785862708661,"version":"3.56.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["GM078114"],"award-info":[{"award-number":["GM078114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jmb.2010.12.028","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T09:19:05Z","timestamp":1293787145000},"page":"491-502","source":"Crossref","is-referenced-by-count":21,"title":["Inhibition of Glycosaminoglycan-Mediated Amyloid Formation by Islet Amyloid Polypeptide and proIAPP Processing Intermediates"],"prefix":"10.1016","volume":"406","author":[{"given":"Fanling","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Raleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2010.12.028_bb0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/10408369409084679","article-title":"Amyloidosis","volume":"31","author":"Sipe","year":"1994","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.jmb.2010.12.028_bb0010","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jmb.2010.12.028_bb0015","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.12.028_bb0020","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.12.028_bb0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diabetes.48.2.241","article-title":"Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes","volume":"48","author":"Kahn","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.12.028_bb0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(87)90825-7","article-title":"Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes","volume":"2","author":"Clark","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2010.12.028_bb0035","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jmb.2010.12.028_bb0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0531-5565(03)00004-4","article-title":"Islet amyloid polypeptide and type 2 diabetes","volume":"38","author":"Marzban","year":"2003","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jmb.2010.12.028_bb0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmb.2010.12.028_bb0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/jmbi.2001.4593","article-title":"Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis","volume":"308","author":"Jaikaran","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2010.12.028_bb0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"pancreatic-islet cell toxicity of amylin associated with type-2 diabetes mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2010.12.028_bb0060","first-page":"151","article-title":"Islet amyloid, increased alpha cells, reduced beta cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes","volume":"9","author":"Clark","year":"1988","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jmb.2010.12.028_bb0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01660981","article-title":"Immunohistology of islet amyloid polypeptide in diabetes mellitus: semiquantitative studies in a post-mortem series","volume":"421","author":"Rocken","year":"1992","journal-title":"Virchows Arch. A: Pathol. Anat. Histopathol."},{"key":"10.1016\/j.jmb.2010.12.028_bb0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.12.028_bb0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/edrv-15-2-163","article-title":"Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease","volume":"15","author":"Cooper","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jmb.2010.12.028_bb0080","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.2337\/db07-1842","article-title":"Islets in type 2 diabetes: in honor of Dr. Robert C. Turner","volume":"57","author":"Bonner-Weir","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.12.028_bb0085","first-page":"2008","article-title":"Amyloid deposition in transplanted human pancreatic islets: a conceivable cause of their long-term failure","author":"Andersson","year":"2008","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.jmb.2010.12.028_bb0090","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMc0802893","article-title":"Widespread amyloid deposition in transplanted human pancreatic islets","volume":"359","author":"Westermark","year":"2008","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jmb.2010.12.028_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00125-008-1185-7","article-title":"Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets","volume":"52","author":"Udayasankar","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jmb.2010.12.028_bb0100","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1073\/pnas.0909024107","article-title":"Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts","volume":"107","author":"Potter","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.12.028_bb0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00265542","article-title":"The insulin secretory granule","volume":"32","author":"Hutton","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.jmb.2010.12.028_bb0110","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/S0021-9258(19)39539-0","article-title":"Islet amyloid polypeptide. A new beta-cell secretory product related to islet amyloid deposits","volume":"265","author":"Nishi","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2010.12.028_bb0115","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1210\/endo.135.4.7925129","article-title":"Developmental expression of the prohormone convertases PC1 and PC2 in mouse pancreatic islets","volume":"135","author":"Marcinkiewicz","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.jmb.2010.12.028_bb0120","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.94.13.6646","article-title":"Defective prohormone processing and altered pancreatic islet morphology in mice lacking active PC2","volume":"94","author":"Furuta","year":"1997","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.12.028_bb0125","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","article-title":"The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site","volume":"50","author":"Wang","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.12.028_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.53.1.141","article-title":"Role of beta-cell prohormone convertase (PC)1\/3 in processing of pro-islet antyloid polypeptide","volume":"53","author":"Marzban","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.12.028_bb0135","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/diabetes.54.7.2117","article-title":"Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation","volume":"54","author":"Paulsson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.12.028_bb0140","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2337\/db05-1566","article-title":"Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death","volume":"55","author":"Marzban","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.12.028_bb0145","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00125-006-0206-7","article-title":"Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets","volume":"49","author":"Paulsson","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jmb.2010.12.028_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/03009734000000057","article-title":"Proislet amyloid polypeptide immunoreactivity in the islets of Langerhans","volume":"105","author":"Westermark","year":"2000","journal-title":"Upsala J. Med. Sci."},{"key":"10.1016\/j.jmb.2010.12.028_bb0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0168-8227(89)90008-9","article-title":"Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans","volume":"7","author":"Westermark","year":"1989","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jmb.2010.12.028_bb0160","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.2337\/db08-0485","article-title":"Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture","volume":"57","author":"Marzban","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.12.028_bb0165","doi-asserted-by":"crossref","first-page":"16611","DOI":"10.1074\/jbc.M008423200","article-title":"Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation","volume":"276","author":"Park","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2010.12.028_bb0170","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1021\/bi0510936","article-title":"Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation","volume":"45","author":"Abedini","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2010.12.028_bb0175","doi-asserted-by":"crossref","first-page":"12091","DOI":"10.1021\/bi7004834","article-title":"Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes","volume":"46","author":"Meng","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2010.12.028_bb0180","first-page":"951","article-title":"Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type ii diabetes mellitus","volume":"116","author":"Young","year":"1992","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jmb.2010.12.028_bb0185","doi-asserted-by":"crossref","first-page":"31617","DOI":"10.1074\/jbc.272.50.31617","article-title":"Heparin-binding properties of the amyloidogenic peptides a beta and amylin. Dependence on aggregation state and inhibition by Congo red","volume":"272","author":"Watson","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2010.12.028_bb0190","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/diabetes.47.4.612","article-title":"Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation","volume":"47","author":"Castillo","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.jmb.2010.12.028_bb0195","first-page":"A223","article-title":"Immuno-identification and localization of heparin sulfate proteoglycans to AA amyloid fibrils in an experimental mouse model of inflammation-associated amyloidosis","volume":"37","author":"Snow","year":"1989","journal-title":"Clin. Res."},{"key":"10.1016\/j.jmb.2010.12.028_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0074-7696(01)10005-7","article-title":"Basement membrane and beta amyloid fibrillogenesis in Alzheimer's disease","volume":"210","author":"Inoue","year":"2001","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.jmb.2010.12.028_bb0205","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0003-9861(03)00116-4","article-title":"Proteoglycans synthesized and secreted by pancreatic islet beta-cells bind amylin","volume":"413","author":"Potter-Perigo","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jmb.2010.12.028_bb0210","doi-asserted-by":"crossref","first-page":"C1586","DOI":"10.1152\/ajpcell.00208.2007","article-title":"Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro","volume":"293","author":"Hull","year":"2007","journal-title":"Am. J. Physiol.: Cell Physiol."},{"key":"10.1016\/j.jmb.2010.12.028_bb0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0197-4580(89)90108-5","article-title":"Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses","volume":"10","author":"Snow","year":"1989","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jmb.2010.12.028_bb0220","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/npp.2008.151","article-title":"Small molecule protein protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles","volume":"34","author":"Blazer","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jmb.2010.12.028_bb0225","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1021\/ar8000475","article-title":"Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation","volume":"41","author":"Takahashi","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jmb.2010.12.028_bb0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio.65","article-title":"Small-molecule aggregates inhibit amyloid polymerization","volume":"4","author":"Feng","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jmb.2010.12.028_bb0235","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1021\/ja072157y","article-title":"A single-point mutation converts the highly amyloidogenic human islet amyloid polypeptide into a potent fibrillization inhibitor","volume":"129","author":"Abedini","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmb.2010.12.028_bb0240","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0507471103","article-title":"Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of iapp cytotoxic fibrillogenesis","volume":"103","author":"Yan","year":"2006","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jmb.2010.12.028_bb0245","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nature05290","article-title":"A century-old debate on protein aggregation and neurodegeneration enters the clinic","volume":"443","author":"Lansbury","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2010.12.028_bb0250","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1002\/anie.200705372","article-title":"Small-molecule inhibitors of islet amyloid polypeptide fibril formation","volume":"47","author":"Mishra","year":"2008","journal-title":"Angew. Chem., Int. Ed."},{"key":"10.1016\/j.jmb.2010.12.028_bb0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmb.2010.12.028_bb0260","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/cbic.200800762","article-title":"Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol","volume":"10","author":"Mishra","year":"2009","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jmb.2010.12.028_bb0265","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1021\/bi901751b","article-title":"The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors","volume":"49","author":"Cao","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2010.12.028_bb0270","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF02442587","article-title":"Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes","volume":"10","author":"Scrocchi","year":"2003","journal-title":"Lett. Pept. Sci."},{"key":"10.1016\/j.jmb.2010.12.028_bb0275","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jmb.2010.05.001","article-title":"The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation","volume":"400","author":"Meng","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2010.12.028_bb0280","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1021\/bi048582a","article-title":"Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions","volume":"43","author":"Porat","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2010.12.028_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506129509031881","article-title":"Thioflavin-T interaction with amyloid beta-sheet structures","volume":"2","author":"Levine","year":"1995","journal-title":"Amyloid"},{"key":"10.1016\/j.jmb.2010.12.028_bb0290","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1021\/bi800828u","article-title":"Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state","volume":"47","author":"Yonemoto","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2010.12.028_bb0295","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1021\/bi702518m","article-title":"Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death","volume":"47","author":"Meng","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2010.12.028_bb0300","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","article-title":"Targeting soluble A-beta peptide with Tramiprosate for the treatment of brain amyloidosis","volume":"28","author":"Gervais","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jmb.2010.12.028_bb0305","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1021\/ol047480+","article-title":"Incorporation of pseudoproline derivatives allows the facile synthesis of human IAPP, a highly amyloidogenic and aggregation-prone polypeptide","volume":"7","author":"Abedini","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.jmb.2010.12.028_bb0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ab.2005.11.029","article-title":"Recovery and purification of highly aggregation-prone disulfide-containing peptides: application to islet amyloid polypeptide","volume":"351","author":"Abedini","year":"2006","journal-title":"Anal. Biochem."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283610013604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283610013604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T18:34:10Z","timestamp":1637087650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283610013604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0022283610013604"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2010.12.028","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}